Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -775.98% is 235% below its 5-year average of -231.37%, near the high end of its 5-year range (-19207.10%–-94.71%).
92.34% above its 12-month average of -10134.64%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -19207.10%.
OPERATING MARGIN
-775.98%
OPERATING MARGIN AVG TTM
-10134.64%
OPERATING MARGIN AVG 3Y
-2789.86%
OPERATING MARGIN AVG 5Y
-231.37%
OPERATING MARGIN AVG 10Y
-365.34%
OPERATING MARGIN AVG 15Y
-499.75%
OPERATING MARGIN AVG 20Y
-468.71%
CURRENT VS TTM AVG
+92.34%
CURRENT VS 3Y AVG
+72.19%
CURRENT VS 5Y AVG
-235.39%
CURRENT VS 10Y AVG
-112.40%
CURRENT VS 15Y AVG
-55.27%
CURRENT VS 20Y AVG
-65.56%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 604 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$258.65M
Operating Margin
-775.98%
TTM Avg
-10134.64%
3Y Avg
-2789.86%
5Y Avg
-231.37%
Market Cap
$259.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$257.48M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$257.11M
Operating Margin
-4.24%
TTM Avg
-7.03%
3Y Avg
-2.53%
5Y Avg
-5.01%
Market Cap
$262.48M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$253.80M
Operating Margin
-13.78%
TTM Avg
-1055.13%
3Y Avg
-2810.33%
5Y Avg
-1873.55%
Market Cap
$250.48M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2313.03%
5Y Avg
-2198.82%
Market Cap
$271.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$245.35M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $258.65M | -775.98% | -10134.64% | -2789.86% | -231.37% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $259.44M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| AC Immune S.A. (ACIU)vs › | $257.48M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.11M | -4.24% | -7.03% | -2.53% | -5.01% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $262.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Century Therapeutics, Inc. (IPSC)vs › | $253.80M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | 0.00% | 0.00% | -2313.03% | -2198.82% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $271.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Invivyd, Inc. (IVVD)vs › | $245.35M | -103.99% | -400.39% | -200.20% | -133.47% |
| Fate Therapeutics, Inc. (FATE)vs › | $272.17M | -2222.45% | -1882.54% | -1096.29% | -863.53% |
Gross Margin
93.4%
Operating Margin
-776.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -19207.10% |
| 2026-03-31 | -12532.47% |
| 2025-12-31 | -11345.97% |
| 2025-09-30 | -6420.81% |
| 2025-06-30 | -1166.83% |
| 2025-03-31 | -199.72% |
| 2024-12-31 | -390.40% |
| 2024-09-30 | -311.17% |
| 2024-06-30 | -364.52% |
| 2024-03-31 | -285.18% |
| 2023-12-31 | -116.58% |
| 2023-09-30 | -94.71% |
| 2023-06-30 | -249.98% |
| 2023-03-31 | -280.54% |
| 2022-12-31 | -415.22% |
| 2022-09-30 | -183.76% |
| 2022-06-30 | -166.16% |
| 2022-03-31 | -196.73% |
| 2021-12-31 | -156.36% |
| 2021-09-30 | -169.04% |
| 2021-06-30 | -121.81% |
| 2021-03-31 | -149.32% |
| 2020-12-31 | -178.61% |
| 2020-09-30 | -12.47% |
| 2020-06-30 | -270.55% |
| 2020-03-31 | -152.81% |
| 2019-12-31 | -104.08% |
| 2019-09-30 | -560.38% |
| 2019-06-30 | -140.98% |
| 2019-03-31 | -728.18% |
| 2018-12-31 | 550.66% |
| 2018-09-30 | -2788.89% |
| 2018-06-30 | -1368.11% |
| 2018-03-31 | -504.09% |
| 2017-12-31 | -622.51% |
| 2017-09-30 | -1560.00% |
| 2017-06-30 | -875.32% |
| 2017-03-31 | -874.58% |
| 2016-12-31 | -1.57% |
| 2016-09-30 | -2594.22% |
| 2016-06-30 | -2123.68% |
| 2016-03-31 | -1572.84% |
| 2015-12-31 | -995.82% |
| 2015-09-30 | -1069.53% |
| 2015-06-30 | -1271.39% |
| 2015-03-31 | -1540.24% |
| 2014-12-31 | -790.02% |
| 2014-09-30 | 82.15% |
| 2014-06-30 | -1373.97% |
| 2014-03-31 | -111.40% |
| 2013-12-31 | -598.14% |
| 2013-09-30 | -622.78% |
| 2013-06-30 | -809.15% |
| 2013-03-31 | -548.15% |
| 2012-12-31 | -452.65% |
| 2012-09-30 | -468.35% |
| 2012-06-30 | -330.47% |
| 2012-03-31 | -506.88% |
| 2011-12-31 | 199.41% |
| 2011-09-30 | -152.56% |
| 2011-06-30 | -8.29% |
| 2011-03-31 | -871.94% |
| 2010-12-31 | -753.86% |
| 2010-09-30 | -721.64% |
| 2010-06-30 | 77.43% |
| 2010-03-31 | -555.92% |
| 2009-12-31 | -3.29% |
| 2009-09-30 | -3.16% |
| 2009-06-30 | 77.19% |
| 2009-03-31 | -24.69% |
| 2008-12-31 | -47.85% |
| 2008-09-30 | -84.78% |
| 2008-06-30 | -186.57% |
| 2008-03-31 | -1219.37% |
| 2007-12-31 | -6278.13% |
| 2007-09-30 | -5061.17% |
| 2007-06-30 | -2575.16% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | -1673.23% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | -5644.47% |
| 2006-05-11 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-11-30 | 100.00% |
| 2005-06-30 | -36139.97% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | -32020.48% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | -5714.95% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
